Cargando…

Postlicensure herpes zoster vaccine effectiveness: systematic review protocol

INTRODUCTION: Herpes zoster (HZ) and associated complications inflict substantial morbidity and associated healthcare and socioeconomic burdens. Current treatments are not fully effective, especially among the most vulnerable populations. Two HZ vaccines are available and are part of the national im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mbinta, James F, Nguyen, Binh P, Awuni, Prosper Mandela A, Eme, Paul E, Simpson, Colin R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907883/ https://www.ncbi.nlm.nih.gov/pubmed/33622942 http://dx.doi.org/10.1136/bmjopen-2020-040964

Ejemplares similares

Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study
por: Mbinta, James F., et al.
Publicado: (2022)

Herpes zoster vaccine safety in the Aotearoa New Zealand population: a self-controlled case series study
por: Mbinta, James F., et al.
Publicado: (2023)

Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA
por: Link-Gelles, Ruth, et al.
Publicado: (2017)

Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data
por: Nelson, Jennifer C, et al.
Publicado: (2022)

Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study
por: Andrews, Nick, et al.
Publicado: (2020)

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018
por: Hesse, Elisabeth M., et al.
Publicado: (2019)

A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
por: Yih, W Katherine, et al.
Publicado: (2022)

Detection of Novel Rotavirus Strain by Vaccine Postlicensure Surveillance
por: Weinberg, Geoffrey A., et al.
Publicado: (2013)

Herpes zoster in SLE: prevalence, incidence and risk factors
por: Kwan, Andrew, et al.
Publicado: (2022)

Herpes zoster risk after 21 specific cancers: population-based case–control study
por: Hansson, Erik, et al.
Publicado: (2017)

Association between de Quervain syndrome and herpes zoster: a population-based cohort study
por: Hsu, Chao-Yu, et al.
Publicado: (2021)

Herpes Zoster Vaccination
por: Kim, Kyung Hoon
Publicado: (2013)

Herpes Zoster Vaccines
por: Harbecke, Ruth, et al.
Publicado: (2021)

The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study
por: Sørensen, H T, et al.
Publicado: (2004)

The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study
por: Cotton, S J, et al.
Publicado: (2013)

Mortality in cancer patients previously diagnosed with herpes zoster in the hospital setting: a nationwide cohort study
por: Schmidt, S A J, et al.
Publicado: (2015)

Incidence of herpes zoster in patients with altered immune function
por: Chen, S.-Y., et al.
Publicado: (2013)

Statistical Power for Postlicensure Medical Product Safety Data Mining
por: Maro, Judith C., et al.
Publicado: (2017)

Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)

Licensing Examination and Crash Outcomes Postlicensure in Young Drivers
por: Walshe, Elizabeth A., et al.
Publicado: (2022)

Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review
por: Mesfin, Yonatan Moges, et al.
Publicado: (2019)

Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
por: Marra, Yasmin, et al.
Publicado: (2022)

Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper
por: García, José María Molero, et al.
Publicado: (2023)

Herpes zoster vaccine in Korea
por: Choi, Won Suk
Publicado: (2013)

Vaccine against herpes zoster
por: Pasternak, Jacyr
Publicado: (2013)

Herpes zoster ophthalmicus or Herpes zoster maxillaris?
por: Chandravanshi, Shivcharan Lal, et al.
Publicado: (2009)

Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022)

Healthy ageing: Herpes zoster infection and the role of zoster vaccination
por: Curran, Desmond, et al.
Publicado: (2023)

Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006–2017
por: Neha, Reddy, et al.
Publicado: (2020)

Cost-Effectiveness of Herpes Zoster Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2019)

Herpes zoster after COVID vaccination
por: van Dam, C.S., et al.
Publicado: (2021)

Systematic Review and Meta-analysis of Herpes Zoster Vaccine in Patients With CKD
por: Hamad, Mohamad A., et al.
Publicado: (2021)

Cost-effectiveness of herpes zoster vaccines in the U.S.: A systematic review
por: Meredith, Neil R., et al.
Publicado: (2022)

2480. Real-World Effectiveness of the Live Zoster Vaccine in Preventing Herpes Zoster: A Systematic Review
por: Saddier, Patricia, et al.
Publicado: (2018)

Herpes Zoster
por: Warneros Loyo, María de Lourdes
Publicado: (1995)

Herpes Zoster
Publicado: (1890)

Herpes Zoster
por: Wile, Henry
Publicado: (1886)

Implications for COVID-19 vaccine uptake: A systematic review
por: Adu, Peter, et al.
Publicado: (2023)

Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
por: Vallianou, Natalia G., et al.
Publicado: (2022)

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
por: Grupping, Katrijn, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j5ib5m1eamk52p91kkf744g2qn